‘The Future Of Pharma Is Still Small-Molecule’ – Axplora Outlines API Investment Strategy

Co-President Of PharmaZell Unit Sets Out API Specialist’s Priorities

 
• By Dave Wallace
  
Anant Barbadikar talks to Generics Bulletin about the API specialist’s strategy (Axplora)

More from Interviews

More from Leadership